Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C

Gastroenterology

Volumn 128, Issue 2, 2005, Pages 343-350

  Castéra, Laurent ^a   Vergniol, Julien ^a   Foucher, Juliette ^a   Le Bail, Brigitte ^b,c   Chanteloup, Elise ^a   Haaser, Maud ^a   Darriet, Monique ^b   Couzigou, Patrice ^a   De Lédinghen, Victor ^a,c  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL PELLEGRIN   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; BIOLOGICAL MARKER;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELASTOGRAPHY; FEMALE; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE; VALIDATION PROCESS; BIOPSY; BLOOD; COMPARATIVE STUDY; ELASTICITY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; ROC CURVE;

ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; ELASTICITY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ROC CURVE;

EID: 12344309018     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.11.018     Document Type: Article

References (40)

1. NIH Consensus Statement on Management of Hepatitis C. 2002 Hepatology 36 2002 S3 S20
2. J.L. Dienstag The role of liver biopsy in chronic hepatitis C Hepatology 36 2002 S152 S160
3. J.F. Cadranel, P. Rufat, F. Degos Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) Hepatology 32 2000 477 481
4. L. Castera, I. Negre, K. Samii, C. Buffet Pain experienced during percutaneous liver biopsy Hepatology 30 1999 1529 1530
5. A.A. Bravo, S.G. Sheth, S. Chopra Liver biopsy N Engl J Med 344 2001 495 500
6. B. Maharaj, R.J. Maharaj, W.P. Leary, R.M. Cooppan, A.D. Naran, D. Pirie Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525
7. A. Regev, M. Berho, L.J. Jeffers, C. Milikowski, E.G. Molina, N.T. Pyrsopoulos Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
8. G. Colloredo, M. Guido, A. Sonzogni, G. Leandro Impact of liver biopsy size on histological evaluation of chronic viral hepatitis the smaller the sample, the milder the disease J Hepatol 39 2003 239 244
9. P. Bedossa, D. Dargère, V. Paradise Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
10. I. Siddique, H.A. El-Naga, J.P. Madda, A. Memon, F. Hasan Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection Scand J Gastroenterol 38 2003 427 432
11. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
12. R.J. Fontana, A.S. Lok Noninvasive monitoring of patients with chronic hepatitis C Hepatology 36 2002 S57 S64
13. F. Oberti, E. Valsesia, C. Pilette, M.C. Rousselet, P. Bedossa, C. Aube Noninvasive diagnosis of hepatic fibrosis or cirrhosis Gastroenterology 113 1997 1609 1616
14. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
15. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, T. Poynard Biochemical markers of liver fibrosis in patients with hepatitis C virus infection a prospective study Lancet 357 2001 1069 1075
16. X. Forns, S. Ampurdanes, J.M. Llovet, J. Aponte, L. Quinto, E. Martinez-Bauer Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
17. K. Patel, A. Lajoie, S. Heaton, S. Pianko, C.A. Behling, D. Bylund Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C J Gastroenterol Hepatol 18 2003 253 257
18. J. Guechot, A. Laudat, A. Loria, L. Serfaty, R. Poupon, J. Giboudeau Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis Clin Chem 42 1996 558 563
19. N. Callewaert, H. Van Vlierberghe, A. Van Hecke, W. Laroy, J. Delanghe, R. Contreras Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics Nat Med 10 2004 429 434
20. L. Sandrin, B. Fourquet, J.M. Hasquenoph, S. Yon, C. Fournier, F. Mal Transient elastography a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
21. M. Beaugrand, M. Ziol, L. Sandrin, C. Fournier, A. Biaggi-Frassati, B. Poulet Liver elasticity measurement by ultrasonic transient elastography a new non-invasive method for assessment of liver fibrosis in chronic viral hepatitis (abstr) Hepatology 38 suppl 1 2003 438A
22. H. Saito, S. Tada, N. Nakamoto, K. Kitamura, H. Horikawa, S. Kurita Efficacy of non-invasive elastometry on staging of hepatic fibrosis Hepatol Res 29 2004 97 103
23. G. Menghini One-second biopsy of the liver--problems of its clinical application N Engl J Med 283 1970 582 585
24. S.M. Marcovina, J.J. Albers, L.O. Henderson, W.H. Hannon International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material Clin Chem 39 1993 773 781
25. F. Dati, G. Schumann, L. Thomas, F. Aguzzi, S. Baudner, J. Bienvenu Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists Eur J Clin Chem Clin Biochem 34 1996 517 520
26. F. Imbert-Bismut, D. Messous, V. Thibaut, R.B. Myers, A. Piton, D. Thabut Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors Clin Chem Lab Med 42 2004 323 333
27. T. Poynard Diagnosis method of inflammatory, fibrotic or cancerous disease using the biochemical markers 2003 United States: Patent No US 6,631,330 B1
28. P. Bedossa, T. Poynard The METAVIR cooperative study group An algorithm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293
29. R.P. Myers, V. Ratziu, F. Imbert-Bismut, F. Charlotte, T. Poynard Biochemical markers of liver fibrosis a comparison with historical features in patients with chronic hepatitis C Am J Gastroenterol 97 2002 2419 2425
30. R.P. Myers, M. De Torres, F. Imbert-Bismut, V. Ratziu, F. Charlotte, T. Poynard Biochemical markers of fibrosis in patients with chronic hepatitis C a comparison with prothrombin time, platelet count, and age-platelet index Dig Dis Sci 48 2003 146 153
31. T. Poynard, F. Imbert-Bismut, V. Ratziu, S. Chevret, C. Jardel, J. Moussalli Biochemical markers of liver fibrosis in patients infected by hepatitis C virus longitudinal validation in a randomized trial J Viral Hepat 9 2002 128 133
32. T. Poynard, J. McHutchison, M. Manns, R.P. Myers, J. Albrecht Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 2003 481 492
33. T. Poynard, M. Munteanu, F. Imbert-Bismut, F. Charlotte, D. Thabut, S. Le Calvez Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 10 2004 10
34. K.A. Gebo, H.F. Herlong, M.S. Torbenson, M.W. Jenckes, G. Chander, K.G. Ghanem Role of liver biopsy in management of chronic hepatitis C a systematic review Hepatology 36 2002 S161 S172
35. N.H. Afdhal Diagnosing fibrosis in hepatitis C is the pendulum swinging from biopsy to blood tests? Hepatology 37 2003 972 974
36. M. Ziol, N. Barget, L. Sandrin, C. Fournier, F. Mal, F. Kazemi Correlation between liver elasticity measured by transient elastography and liver fibrosis assessed by morphometry in patients with HCV chronic hepatitis (abstr) J Hepatol 40 suppl 1 2004 459
37. E. Rossi, L. Adams, A. Prins, M. Bulsara, B. de Boer, G. Garas Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients Clin Chem 49 2003 450 454
38. D. Thabut, M. Simon, R.P. Myers, D. Messous, V. Thibault, F. Imbert-Bismut Noninvasive prediction of fibrosis in patients with chronic hepatitis C Hepatology 37 2003 1220 1221
39. P. Halfon, M. Bourliere, R. Deydier, I. Portal, C. Renou, J.J. Bertrand Independent prospective multicenter validation of biochemical markers (Fibrotest-Actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C (abstr) Hepatology 38 suppl 1 2003 188A
40. S. Le Calvez, D. Thabut, D. Messous, M. Munteanu, V. Ratziu, F. Imbert-Bismut The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C Hepatology 39 2004 862 863